ABC4 Consensus: First Latin American Meeting—Assessment, Comments, and Application of Its Recommendations

Henry L. Gomez, Carlos Castañeda, Fernando Valencia, Rene Muñoz-Bermeo, Maria del Carmen Torrico, Silvia Neciosup

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

1 Cita (Scopus)

Resumen

Breast cancer accounts for a high burden among all the neoplasms in Latin America, with more-advanced stages at presentation, which could result in high mortality rates. The 4th International Consensus Conference for Advanced Breast Cancer (ABC4) is focused on standardizing therapy for advanced breast cancer (ABC) and has held 5 meetings so far. ABC4 took place in Lisbon, Portugal, from November 2 to 4, 2017; however, the first Latin American ABC conference was held in Lima, Peru, from 18 to 19 May, 2018, chaired by Fatima Cardoso, MD, PhD. During these 2 days, the ABC4 consensus recommendations for advanced and locally advanced breast cancer were presented. Local treatment and systemic therapy were discussed with local experts, mainly focusing on anti–human epidermal growth factor receptor 2 therapy and newly approved drugs for hormone receptor–positive breast cancer, such as as CDK4/6, mammalian target of rapamycin, and poly (ADP-ribose) polymerase inhibitors for triple-negative breast cancer. The discussion focused additionally on access to drugs and ABC4 consensus recommendations as regards Latin American patients.

Idioma originalInglés
Páginas (desde-hasta)819-827
Número de páginas9
PublicaciónJCO Global Oncology
N.º6
DOI
EstadoPublicada - 15 jun 2020

Nota bibliográfica

Publisher Copyright:
© 2020 by American Society of Clinical Oncology

Huella

Profundice en los temas de investigación de 'ABC4 Consensus: First Latin American Meeting—Assessment, Comments, and Application of Its Recommendations'. En conjunto forman una huella única.

Citar esto